Healix Infusion Therapy is categorized under Rehabilitation Center, Outpatient Treatment in Sugar Land, TX and active since 2010.
Healix Infusion Therapy was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Mike Mcdonald at the company’s single location by writing to 1075 West Park One Drive, Sugar Land, Texas TX 77478 or by phoning (281) 240-2190. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Healix Infusion Therapy |
Contact Person: | Mike Mcdonald |
Address: | 1075 West Park One Drive, Sugar Land, Texas 77478 |
Phone Number: | (281) 240-2190 |
Annual Revenue (USD): | Unknown |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 9999900 |
Share This Business: |
Healix Infusion Therapy was started in 2010 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Mike Mcdonald for inquiries that concern Healix Infusion Therapy by calling the company number (281) 240-2190, as your correspondence is most welcome. Additionally, the physical location of the single location of Healix Infusion Therapy can be found at the coordinates 29.64147,-95.60995 as well as the street address 1075 West Park One Drive in Sugar Land, Texas 77478.
For its online presence, you may visit Healix Infusion Therapy’s website at and engage with its social media outlets through on Twitter and on Facebook.